Therapeutic management of stroke-like episodes varies from that of encephalitis

Josef Finsterer1

  • 1Krankenanstalt Rudolfstiftung, Messerli Institute, Vienna, Austria.

Medicine
|February 22, 2020
PubMed
Abstract

Insights

Stroke-like lesions (SLLs) in mitochondrial disorders (MIDs) present as vasogenic edema. These lesions dynamically change and require differentiation from ischemic stroke for appropriate treatment.

Area of Science:

  • Neurology
  • Mitochondrial Medicine
  • Neuroimaging

Background:

  • Stroke-like episodes (SLEs) are characteristic cerebral manifestations of mitochondrial disorders (MIDs).
  • These episodes manifest as stroke-like lesions (SLLs) on cerebral MRI, defined by vasogenic edema in non-vascular distributions.
  • SLLs exhibit dynamic changes, expanding in the acute phase and regressing in the chronic phase, with altered perfusion patterns.

Observation:

  • SLLs exhibit dynamic changes, expanding in the acute phase and regressing in the chronic phase.
  • Acute SLLs show hyperperfusion, while chronic SLLs demonstrate hypoperfusion on imaging.
  • These lesions can evolve into various outcomes, including normal tissue, white or grey matter lesions, cysts, or laminar cortical necrosis.

Findings:

  • SLLs are a common manifestation of MIDs.
  • Treatment interventions such as antiseizure drugs, steroids, ketogenic diet, and antioxidants show favorable responses.
  • Distinguishing SLLs from ischemic stroke is critical for appropriate management.

Implications:

  • Understanding the distinct nature of SLLs in MIDs is essential for accurate diagnosis and treatment.
  • The dynamic nature and varied outcomes of SLLs necessitate tailored therapeutic strategies.
  • This research highlights the importance of neuroimaging in identifying and monitoring SLLs in mitochondrial disease patients.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
124
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
741
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
164
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
674